drugset / Trial / NCT01928901

Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)

NCT01928901 ↗

Phase 2 Completed 56 enrolled Bionorica SE
RandomizedCrossoverDouble-blindBasic science

Summary

Proof of concept: Superiority of Bronchipret or Sinupret to placebo in respect to mucociliary clearance

Timeline

Start
2013-08
Primary completion
2013-12
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bronchipret Unknown 2 unknown —
Subject Sinupret Unknown 2 unknown —

Indications

No indication recorded.